AIRE gene's role in autoimmune nerve diseases
Part of Bones, joints & muscles, Brain & nervous system, Cancer, Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how the AIRE gene affects people with autoimmune nerve diseases like NMOSD, myasthenia gravis, and autoimmune encephalitis when they also have other autoimmune conditions. It may help researchers understand why some people get multiple autoimmune problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have NMOSD with AQP4 antibodies, myasthenia gravis with AChR antibodies, or autoimmune encephalitis with LGI1 or CASPR2 antibodies
- You have at least one additional autoimmune condition (like lupus, thyroid disease, etc.)
- You do not have an untreated thymoma or history of thymoma
- You are 18 or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses lab-grown mini muscle-nerve cells (organoids) to better understand severe, hard-to-treat myasthenia gravis. It may help researchers find new treatment options for people with the AChR antibody type.
This study follows patients with autoimmune encephalitis (brain inflammation caused by the immune system) to see how treatments affect them in the medium term. It may help doctors learn which treatments work best for people with this condition.
This trial is testing an experimental cell therapy called azer-cel for people with certain autoimmune diseases that affect the nervous system. The therapy aims to reduce immune attacks on the body by targeting and removing faulty B cells.
This study looks for biomarkers (biological clues) in people with autoimmune diseases of the nervous system. It aims to discover better ways to diagnose and treat these conditions.
This study tests a new treatment called CC-97540 (a type of CAR T-cell therapy) for people with neuromyelitis optica spectrum disorder (NMOSD), which is an autoimmune disease that affects the eyes and spinal cord. The goal is to see if this treatment is safe and tolerable.
This study looks at children who have had a first attack of nerve inflammation (like ADEM, vision loss, or spinal cord issues) to find markers in the blood that might show if it will come back. It tests blood and cells to better understand the immune response.
Hear when a new AIRE Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.